Back to Search
Start Over
Complete resolution of chylopericardium after chemotherapy for chronic lymphocytic leukemia.
- Source :
-
Current oncology (Toronto, Ont.) [Curr Oncol] 2019 Oct; Vol. 26 (5), pp. e696-e699. Date of Electronic Publication: 2019 Oct 01. - Publication Year :
- 2019
-
Abstract
- Nontraumatic chylous pleural effusions (chylothorax) and pericardial effusions (chylopericardium) are rare. They can, however, accompany intrathoracic malignancies and, most commonly, lymphomas. An association of chronic lymphocytic leukemia (cll) with chylopericardium has rarely been reported. A 68-year-old woman with cll, previously treated with single-agent fludarabine in the community, developed pleuritic chest pain and a new pericardial effusion. Computed tomography (ct) imaging of her chest revealed a large pericardial effusion with progressive lymphadenopathy. Pericardiocentesis identified a chylous effusion, and complete evacuation was achieved by catheter drainage. The cll was not treated. An asymptomatic pericardial effusion subsequently recurred. Pericardiocentesis was not repeated. Lymph node biopsy and flow cytometry revealed no evidence of large-cell lymphoma transformation. The patient was treated with 6 cycles of chlorambucil and obinutuzumab. Imaging of her chest by ct between cycles 2 and 3 revealed a marked resolution of the intrathoracic lymphadenopathy, with complete disappearance of the pericardial effusion. Repeat imaging at 5 months and again at 3 years after completion of chemotherapy demonstrated no recurrence of either the lymphadenopathy or the pericardial effusion. The mechanism of production and the treatment of chylous effusions are poorly defined. In this case, resolution of the pericardial effusion with effective chemotherapy is postulated to have alleviated obstruction of anterograde lymphatic flow facilitating drainage into the systemic venous system and allowing for spontaneous complete resolution of the pericardial effusion without surgical intervention.<br />Competing Interests: CONFLICT OF INTEREST DISCLOSURES We have read and understood Current Oncology’s policy on disclosing conflicts of interest, and we declare that we have none.<br /> (2019 Multimed Inc.)
- Subjects :
- Aged
Female
Humans
Leukemia, Lymphocytic, Chronic, B-Cell complications
Leukemia, Lymphocytic, Chronic, B-Cell diagnostic imaging
Pericardial Effusion etiology
Positron-Emission Tomography
Tomography, X-Ray Computed
Treatment Outcome
Antibodies, Monoclonal, Humanized therapeutic use
Antineoplastic Agents, Alkylating therapeutic use
Antineoplastic Agents, Immunological therapeutic use
Chlorambucil therapeutic use
Leukemia, Lymphocytic, Chronic, B-Cell drug therapy
Pericardial Effusion drug therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1718-7729
- Volume :
- 26
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- Current oncology (Toronto, Ont.)
- Publication Type :
- Academic Journal
- Accession number :
- 31708663
- Full Text :
- https://doi.org/10.3747/co.26.5039